132 related articles for article (PubMed ID: 16392308)
21. Second study on valsartan is threatened with retraction over alleged data manipulation.
Mahony C
BMJ; 2013 Aug; 347():f4920. PubMed ID: 23918698
[No Abstract] [Full Text] [Related]
22. [A case of valsartan-induced pneumonitis with marked elevation of serum KL-6].
Takakura A; Kubota M; Otani S; Katono K; Yamamoto M; Masuda N
Nihon Kokyuki Gakkai Zasshi; 2011 Jul; 49(7):523-7. PubMed ID: 21842690
[TBL] [Abstract][Full Text] [Related]
23. Angioedema and photosensitive rash induced by valsartan.
Frye CB; Pettigrew TJ
Pharmacotherapy; 1998; 18(4):866-8. PubMed ID: 9692664
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of atherosclerotic renal artery stenosis. Low dosage ACE inhibitors and angiotensin-receptor blockers are justified in certain cases].
Alhadad A; Sterner G; Herlitz H
Lakartidningen; 2009 Oct 28-Nov 3; 106(44):2836-8, 2840. PubMed ID: 19967962
[No Abstract] [Full Text] [Related]
25. Angiotensin converting enzyme inhibition and renal insufficiency in patients with bilateral renovascular disease.
Dominiczak A; Isles C; Gillen G; Brown JJ
J Hum Hypertens; 1988 Jun; 2(1):53-6. PubMed ID: 3070034
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation.
Sugihara M; Miura S; Takamiya Y; Kiya Y; Arimura T; Iwata A; Kawamura A; Nishikawa H; Uehara Y; Saku K
Hypertens Res; 2009 Jul; 32(7):625-30. PubMed ID: 19461652
[TBL] [Abstract][Full Text] [Related]
27. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
28. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
29. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
[TBL] [Abstract][Full Text] [Related]
30. In-stent restenosis of the renal artery in a single kidney patient: the role of ACEI in the therapeutic choice.
Cianci R; Gigante A; Polidori L; Di Donato D; Martina P; Barbano B; Renzulli R; Zaccaria A; Fuiano G
Angiology; 2009; 60(4):496-503. PubMed ID: 18796449
[TBL] [Abstract][Full Text] [Related]
31. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
32. [Bilateral renal artery stenosis--a cause of acute pulmonary edema].
Høieggen A; Draganov B; Os I
Tidsskr Nor Laegeforen; 2001 Jun; 121(15):1789-90. PubMed ID: 11464682
[TBL] [Abstract][Full Text] [Related]
33. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.
Zanchetti A; Julius S; Kjeldsen S; McInnes GT; Hua T; Weber M; Laragh JH; Plat F; Battegay E; Calvo-Vargas C; Cieśliński A; Degaute JP; Holwerda NJ; Kobalava J; Pedersen OL; Rudyatmoko FP; Siamopoulos KC; Störset O
J Hypertens; 2006 Nov; 24(11):2163-8. PubMed ID: 17053536
[TBL] [Abstract][Full Text] [Related]
34. VALUE: analysis of results.
Sever P
Lancet; 2004 Sep 11-17; 364(9438):933-4; author reply 935. PubMed ID: 15364180
[No Abstract] [Full Text] [Related]
35. Valsartan inefficacy or ill-effects of concomitant medications!
Bangalore S; Messerli FH
Am J Cardiol; 2010 Aug; 106(4):602-3. PubMed ID: 20691326
[No Abstract] [Full Text] [Related]
36. The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.
Saiki A; Ohira M; Endo K; Koide N; Oyama T; Murano T; Miyashita Y; Shirai K
Diabetes Res Clin Pract; 2006 Dec; 74(3):242-8. PubMed ID: 16713009
[TBL] [Abstract][Full Text] [Related]
37. Valsartan/hydrochlorothiazide: pharmacology and clinical efficacy.
Kondrack R; Mohiuddin S
Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1125-34. PubMed ID: 19689218
[TBL] [Abstract][Full Text] [Related]
38. Valsartan, captopril, or both in myocardial infarction.
Moshenyat R; Kupfer Y; Tessler S
N Engl J Med; 2004 Feb; 350(9):943-5; author reply 943-5. PubMed ID: 14988935
[No Abstract] [Full Text] [Related]
39. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
[TBL] [Abstract][Full Text] [Related]
40. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
Onuigbo MA
Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
